← SynDRA
GANETESPIB
SynDRA canonical compound SYN0030077 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | HSP90AA1 |
| Mechanism of action | HSP inhibitor |
All known targets
Mechanisms of action (all sources)
- HSP inhibitor
- HSP90AA1 INHIBITOR
- Heat shock protein HSP90 inhibitor
- HSP90AB1 INHIBITOR
Cross-references
Synonyms
- STA-9090
- Ganetespib (STA-9090)
- STA 9090
- STA9090
- Ganetespib [USAN]
- Ganetespib(STA-9090)
- 5-[2,4-Dihydroxy-5-(1-methylethyl)phenyl]-2,4-dihydro-4-(1-methyl-1H-indol-5-yl)-3H-1,2,4-triazol-3-one
- Ganetespib (USAN)
- 2E8412Y946
- 3-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-(1-methylindol-5-yl)-1H-1,2,4-triazol-5-one
- (5Z)-5-(4-hydroxy-6-oxo-3-propan-2-ylcyclohexa-2,4-dien-1-ylidene)-4-(1-methylindol-5-yl)-1,2,4-triazolidin-3-one
- 3-(2,4-Dihydroxy-5-isopropylphenyl)-4-(1-methyl-1H-indol-5-yl)-1H-1,2,4-triazol-5(4H)-one
- 3-[2,4-Dihydroxy-5-(propan-2-yl)phenyl]-4-(1-methyl-1H-indol-5-yl)-4,5-dihydro-1H-1,2,4-triazol-5-one
- 4-(5-hydroxy-4-(1-methyl-1H-indol-5-yl)-4H-1,2,4-triazol-3-yl)-6-isopropylbenzene-1,3-diol
- 5-(2,4-Dihydroxy-5-(1-methylethyl)phenyl)-4-(1-methyl-1H-indol-5-yl)-2,4-dihydro-3H- 1,2,4-triazol-3-one
- 5-[2,4-dihydroxy-5-(1-methylethyl)phenyl]-4-(1-methyl-1H-indol-5-yl)-2,4-dihydro-3H- 1,2,4-triazol-3-one
- 5-[2,4-Dihydroxy-5-(Propan-2-Yl)phenyl]-4-(1-Methyl-1h-Indol-5-Yl)-2,4-Dihydro-3h-1,2,4-Triazol-3-One
- Ganetespib [USAN:INN]
- Genetespib
- UNII-2E8412Y946
- 5-(2,4-DIHYDROXY-5-(PROPAN-2-YL)PHENYL)-4-(1-METHYL-1H-INDOL-5-YL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE
- 3-(2,4-Dihydroxy-5-isopropylphenyl)-4-(1-methylindol-5-yl)-5-hydroxy-4H-1,2,4-triazole
- Ganetespib,STA-9090
- GANETESPIB [INN]
- Ganetespib - STA-9090
- GANETESPIB [WHO-DD]
- SCHEMBL419750
- CHEMBL2103879
- EX-A250
- CHEBI:177770
- DTXSID401025663
- HMS3654K12
- HMS3673E09
- AMY16782
- BCP22669
- BDBM50439621
- MFCD22420818
- NSC765435
Look up GANETESPIB in the interactive SynDRA portal →